Gene Transfer Clinical Trial for Duchenne Muscular Dystrophy Using rAAVrh74.MCK.GALGT2

Clinical trial NCT02704325 · WITHDRAWN

Trial details

NCT number: NCT02704325
Sponsor: Kevin Flanigan
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Duchenne Muscular Dystrophy

Start date: 2016-04-01
Primary completion: 2018-07-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.